Live Chat

Berdagang Novavax NVAX

Jual
 Beli

Novavax carta live

5m 15m 30m 1h 4h 1d 1w

Asas Instrumen

Weekly Search
Weekly
Daily
Tarikh Tutup Perubahan Perubahan (%): Buka Tinggi Rendah

Berita Terkini

Frances Wang 2024 Dec 23, 16:00

SPOT stock price: Spotify stock reaches all-time highs

Stocks
Frances Wang 2024 Dec 23, 16:00

DRCT stock price today: Direct Digital Holdings spikes on high-volume move

Stocks
Frances Wang 2024 Dec 23, 16:00

Stock Market Today: Dow Jones Closes Higher for Third Consecutive Day

Stocks
GDP data
Dyogenes Diniz 2024 Dec 22, 17:00

Morning Note: GDP in the UK, Spain and Canada to Shake Markets Today

Frances Wang 2024 Dec 22, 16:00

Bitcoin ETFs Experience Record Outflows Amid Crypto Market Decline

Cryptocurrencies ETFs
Frances Wang 2024 Dec 19, 16:00

Analyst revises Amazon stock forecast following major 'moonshot' initiative

Stocks
Frances Wang 2024 Dec 19, 16:00

Stock market today: 3 bullish stocks that J.P. Morgan Just Upgraded

Stocks
Frances Wang 2024 Dec 19, 16:00

Bitcoin news today: Jerome Powell Says Fed Won’t Hold Bitcoin

Cryptocurrencies

Maklumat

Sebaran nilai

0.07

Spread (%)

0.8284 %

Leveraj

1:5

Faedah semalaman (Beli)

-0.0597 %

Faedah semalaman (Jual)

-0.0292 %

Mata wang

USD

Waktu perdagangan

Pasaran ditutup

Khamis

14:31 - 20:59

Isnin

14:31-20:59

Selasa

14:31-17:59

Jumaat

14:31-20:59

Analisis dan statistik

Buka

---

Tutup Terdahulu

---

Tinggi/Rendah 52 Minggu

--- – ---

Modal pasaran

1383998336

Saham Tertunggak

160184992

Tarikh Pendapatan (Seterusnya)

2019-05-10

Hasil Div

2019-05-10

Tarikh Selepas Dividen

Kadar dividen tahunan depan

0

Hasil dividen tahunan depan

0

EPS

-2.18

Ketahui lebih lanjut mengenai instrumen ini

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Instrumen Berkaitan

Aset
Jual
Beli
Perubahan (%):

Berdaganglah Sekarang

Berdaganglah Sekarang

Berdaganglah Sekarang

Berdaganglah Sekarang
Instrumen Berkaitan
Trustpilot
Live Chat